Option Care Health Inc

Latest Results (22.11.2025):

Option Care Health Inc — Third Quarter 2024: The company reported strong top-line growth with net revenue of $1,278.5 million (up 17.0% year‑over‑year) while GAAP net income was $53.9 million ($0.31 diluted EPS), modestly below prior year. Adjusted results showed solid operating performance (Adjusted EBITDA up 5.3%), and operating cash flow strengthened materially. Management updated full‑year 2024 guidance while continuing share repurchases.

Revenue

Net revenue of $1,278.5 million in Q3 2024, up 17.0% versus $1,093.0 million in Q3 2023.

Gross profit and margin

Gross profit of $256.7 million, representing 20.1% of net revenue in Q3 2024 (versus $254.3 million and 23.3% in Q3 2023); gross dollars rose slightly while margin declined.

Net income & EPS

GAAP net income was $53.9 million, or $0.31 diluted EPS, down ~4.3% from $56.3 million (also $0.31 diluted EPS) in Q3 2023.

Adjusted results

Adjusted net income of $70.7 million, or $0.41 adjusted diluted EPS (down ~3.2% vs prior year adjusted net income of $73.1 million); Adjusted EBITDA was $115.6 million, up 5.3% versus $109.8 million in Q3 2023.

Cash flow & liquidity

Operating cash flow was $160.4 million in the quarter (vs. $61.0 million in Q3 2023). Cash and cash equivalents totaled $483.0 million at quarter end.

Capital deployment

Repurchased approximately $41.9 million of common stock in Q3 2024.

Updated full‑year 2024 guidance

Management expects full‑year net revenue of $4.90B–$4.95B, Adjusted EBITDA of $438M–$443M, cash flow from operations of at least $300M, an effective tax rate of 26%–28%, and net interest expense of ~$55M–$60M.

Balance sheet & leverage

Total assets were $3,427.7 million and total liabilities $2,001.5 million at 9/30/2024; long‑term debt, net was ~$1,105.1 million. Notable working capital items include accounts receivable ~$429.0 million, inventories ~$310.6 million, and accounts payable ~$592.0 million.